Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Korea Improves New Drug Pricing Incentives After Industry Calls

This article was originally published in PharmAsia News

Executive Summary

South Korea’s government is moving to improve reimbursement prices for new drugs developed by domestic companies amid repeated calls from the pharma industry, as part of a series of measures to increase R&D incentives for novel drugs that will be approved locally for the first time in the world.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register